WuXi Biologics (Cayman) Inc WXXWY:OTCPK

*Data is delayed | Exchange | USD
Last | 04/24/24 EDT
3.25quote price arrow down-0.03 (-0.91%)
Volume
78,060
52 week range
3.14 - 13.25
Loading...
  • Open3.28
  • Day High3.28
  • Day Low3.22
  • Prev Close3.28
  • 52 Week High13.25
  • 52 Week High Date11/15/23
  • 52 Week Low3.14
  • 52 Week Low Date04/22/24

Key Stats

  • Market Cap6,859.62M
  • Shares Out4,259.28M
  • 10 Day Average Volume151,788.1
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-56.38

KEY STATS

  • Open3.28
  • Day High3.28
  • Day Low3.22
  • Prev Close3.28
  • 52 Week High13.25
  • 52 Week High Date11/15/23
  • 52 Week Low3.14
  • 52 Week Low Date04/22/24
  • Market Cap6,859.62M
  • Shares Out4,259.28M
  • 10 Day Average Volume151,788.1
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-56.38

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On WuXi Biologics (Cayman) Inc

 

Profile

MORE
WuXi Biologics Cayman Inc is an investment holding company principally engaged in provision of discovery, development and manufacturing services of biologics. Through fully-integrated biologics Contract Research, Development and Manufacturing Organization (CRDMO), the Company provides one-stop end-to-end biologics services. Biologics development process stages include pre-IND (drug discovery and pre-clinical development), early-phase (phases I & II) clinical development...
Ge Li Ph.D.
Non-Executive Chairman of the Board
Zhisheng Chen
Chief Executive Officer, Executive Director
Ming Tu
Chief Financial Officer
Jijie Gu Ph.D.
Executive Vice President, Chief Scientific Officer
Address
No. 108, Meiliang Road, Mashan
Wuxi, JNG
China